A Phase 4 interventional study of Blood transfusion in Pulmonary Hypertension, sponsored by Medical University of Vienna. Terminated at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-27.
Sponsored by Medical University of Vienna · Phase 4, Interventional, and Treatment
Transfusion of stored blood has been associated with increased pulmonary vascular resistance in lambs. The investigators hypothesize that transfusion of one unit of red blood cells stored under standard conditions in intensive care patients will increase pulmonary arterial pressure and pulmonary vascular resistance to a greater extent than will one unit of fresh red blood cells.
1,105 studies on the registry are indexed under Hypertension, Pulmonary; 234 are open to participants now.
This study's enrollment of 11 is below the median of 35 across 649 interventional studies indexed under Hypertension, Pulmonary.
Browse Hypertension, Pulmonary studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
One unit of blood stored for less than 14 days
Biological: Blood transfusion
One unit of blood stored under standard conditions
Biological: Blood transfusion
One unit of red blood cells will be transfused over the course of 20 minutes
Pulmonary arterial pressure
Time frame: Change from baseline to immediately after transfusion (time frame of 20 min)
Pulmonary vascular resistance
Time frame: Change from baseline to immediately after transfusion (time frame of 20 min)
Systemic pressure
Time frame: Change from baseline to immediately after transfusion (time frame of 20 min)
Systemic vascular resistance
Time frame: Change from baseline to immediately after transfusion (time frame of 20 min)
This study is terminated, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna